Neodymium-doped yttrium aluminium garnet laser treatment for onychomycosis
HAYES, Inc
Record ID 32017000392
English
Authors' recommendations:
Onychomycosis is a fungal infection of the nail. Onychomycosis can cause discomfort, pain, and disfigurement leading to serious physical and occupational limitations. Onychomycosis is a deepseated,
recalcitrant condition with a 40% to 70% recurrence rate, which includes either relapse or reinfection. Oral antifungals are the standard of care because topical application has limited effectiveness due to the difficulty of nail penetration. However, systemic antifungals are associated with hepatic toxicity and drug interactions. Additionally, topical or oral antifungal treatment must be maintained for several months for maximal effectiveness, and patient compliance is a common issue.
Description of Technology: Neodymium-doped yttrium aluminium garnet (Nd:YAG) lasers typically have a wavelength of 1064 nanometers and a variety of pulse durations to impact the power of laser treatment, including long-pulsed (milliseconds), short-pulsed (microseconds), and Qswitched (nanoseconds).
Patient Population: Laser therapy is indicated for patients with toenail or fingernail onychomycosis.
Clinical Alternatives: Onychomycosis may be treated with oral (e.g., terbinafine, itraconazole, fluconazole, posaconazole, griseofulvin) or topical (e.g., ciclopirox olamine, efinaconazole, amorolfine, bifonazole, tioconazole, tavaborate) antifungal agents or nonpharmacologic treatments (e.g., laser treatment, photodynamic therapy, nail debridement, nail evulsion). Pharmacologic and nonpharmacologic treatments may also be used in combination.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=64446
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Lasers, Solid-State
- Neodymium
- Onychomycosis
- Phosphatidylethanolamines
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.